BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26708385)

  • 1. Increasing demonstration of angiogenic markers in skin neoplastic lesions.
    de Almeida CM; de Jesus SF; Poswar Fde O; Gomes ES; Fraga CA; Farias LC; Santos SH; Feltenberger JD; de Paula AM; Guimarães AL
    Pathol Res Pract; 2016 Feb; 212(2):101-5. PubMed ID: 26708385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
    Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
    Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour.
    Chin CW; Foss AJ; Stevens A; Lowe J
    J Pathol; 2003 Jul; 200(3):308-13. PubMed ID: 12845626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
    Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
    Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis.
    Giuffrè G; Barresi V; Catalano A; Cappiello A; Stagno d'Alcontres F; Tuccari G
    Eur J Histochem; 2008; 52(1):53-60. PubMed ID: 18502723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic switch occurs late in squamous cell carcinomas of human skin.
    Strieth S; Hartschuh W; Pilz L; Fusenig NE
    Br J Cancer; 2000 Feb; 82(3):591-600. PubMed ID: 10682671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
    Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
    Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS; Teleman S; Ungureanu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry.
    Newell B; Bedlow AJ; Cliff S; Drysdale SB; Stanton AW; Mortimer PS
    Br J Dermatol; 2003 Jul; 149(1):105-10. PubMed ID: 12890202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians.
    Halpern AC; Hanson LJ
    Int J Dermatol; 2004 Sep; 43(9):638-42. PubMed ID: 15357741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing the vascular history of nonmelanoma skin tumors: an in vivo human study.
    Tehrani H; McArthur P; Dalal M
    Ann Plast Surg; 2013 Jun; 70(6):717-9. PubMed ID: 23364673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.